Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer
Clinical trial NCT03086642 · COMPLETED
Trial details
- NCT number
- NCT03086642
- Sponsor
- Karie D. Runcie, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2021-05-13
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.